DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Sign in and take the values quiz to see how this bill lines up with what you've said.
This bill amends Medicare law to allow breakthrough medical devices that have received FDA approval to qualify for conditional Medicare New Technology Add-On Payments (NTAP) even if they miss the standard approval deadline, provided they receive FDA clearance before July 1 of the fiscal year in question. The bill defines 'breakthrough devices' as those designated for expedited FDA review and priority consideration. The provision is implemented in a budget-neutral manner and applies retroactively to devices approved on or after July 1, 2023.
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
Sign in to see how your representatives voted on this bill.